Search results
Showing 1 to 6 of 6 results for riluzole
Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease (TA20)
Evidence-based recommendations on the use of riluzole (Rilutek) for treating motor neurone disease (MND).
Masitinib with riluzole for treating amyotrophic lateral sclerosis ID6257
In development [GID-TA11071] Expected publication date: TBC
Masitinib with riluzole for treating amyotrophic lateral sclerosis TS ID 10728
Awaiting development [GID-TA11071] Expected publication date: TBC
Sézary syndrome [ID1405] 11 May 2021 TA020 Motor neurone disease - riluzole 4 January 2001 TA129 Multiple myeloma - Bortezomib 8 February
This guideline covers assessing and managing motor neurone disease (MND). It aims to improve care from the time of diagnosis, and covers information and support, organisation of care, managing symptoms and preparing for end of life care.